Algernon Pharmaceuticals (QB) Stock Price - AGNPF

0.00556 (7.69%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Algernon Pharmaceuticals Inc (QB) AGNPF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00556 7.69% 0.07786 0.07 0.083 0.07 0.0723 16:55:03
Bid Price Ask Price Spread Spread % News
0.027 0.1328 0.1058 79.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
95 586,611 $ 0.075935 $ 44,544 46,493 0.036 - 0.083
Last Trade Time Type Quantity Stock Price Currency
15:27:55 10,000 $ 0.07786 USD

Algernon Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.59M 71.75M - - 58.63M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.29k $ - 0.00% - -

more financials information »

Algernon Pharmaceuticals (QB) News

Loading Messages....

Latest AGNPF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGNPF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.060.0830.05780.068030811,9780.0178629.77%
1 Month0.0670.0830.0440.058795822,6670.0108616.21%
3 Months0.040.0830.0360.057058637,4440.0378694.65%
6 Months0.040.0830.0360.057058637,4440.0378694.65%
1 Year0.040.0830.0360.057058637,4440.0378694.65%
3 Years0.040.0830.0360.057058637,4440.0378694.65%
5 Years0.040.0830.0360.057058637,4440.0378694.65%

Algernon Pharmaceuticals (QB) Description

The company is a clinical stage pharmaceutical development company focused on the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). The company's key compounds were identified using a drug repurposing strategy.

Your Recent History
Algernon P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.